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CHAPTER 0: ABSTRACT 
End Stage Renal Disease is a serious burden for both patients and health care professional 
mainly in the public service in South Africa. 
Haemodialysis is currently overstretched. 
All patients accepted in the state renal programme have to start with Continuous Ambulatory 
Peritoneal Dialysis (CAPD). Our study focused on patients treated by CAPD. One of the 
most common complications of CAPD is peritonitis. 
The files of 115 patients who attended the Renal Unit were reviewed and 91 met our 
inclusion criteria. This is a case control study where the cases were patients with peritonitis.   
Forty five patients developed peritonitis. The racial composition was: twenty four Indians 
(53. 3%), followed by the eighteen Africans (40%), the coloured and white group had two 
and one respectively, a total of three participants (6.7%). The study revealed that females 
were significantly more affected by peritonitis than males p=0.00466 
There was no significant difference between Africans and Indians (p=0.2048). The study 
showed that among the co morbidities, only obesity and Diabetes Mellitus (DM) were 
significantly associated with the development of peritonitis. 
While bacterial peritonitis was the most prevalent at any stage, fungal peritonitis occurred 
only after one year. 
In conclusion this study highlights the spectrum of microbiology of peritonitis in CAPD 
patients.  Furthermore the study showed there is a need to broaden the laboratory routine 
method screening for emerging microorganisms like Rhodotorula sp, a fungus isolated during 









CHAPTER 1: INTRODUCTION 
1.1 Introduction 
Globally, peritonitis presents acute complications of peritoneal dialysis that leads to increase 
in hospitalization, morbidity and mortality amongst continuous ambulatory peritoneal dialysis 
patients (Okpechi et al. 2010; Canusa.1996). According to Vikrant et al. (2013) peritonitis is a 
leading cause of catheter loss and technical failure of the equipment used to manage peritonitis. 
Peritonitis which is the inflammation of the peritoneum may not be caused by infection and 
arguably rendering it the leading cause of catheter and technical failures in the management of 
this condition (Kerschbaum et al. 2012; Vikrant et al. 2013). Literature demonstrates that there 
are different micro-organisms responsible for peritonitis depending on a number of variables 
such as geographical space, socio-demographic factors and the status of the immune system 
(Troidle et al.1998; Prasad et al. 2007). Hence, this study sought to understand the peritonitis 
incidences and dynamics over two years using the Continuous Ambulatory Peritoneal Dialysis 
(CAPD) cases (patients), at Inkosi Albert Luthuli Central Hospital (IALCH), Durban in South 
Africa. 
 
Literature demonstrates that the concept of peritonitis has evolved more through experience 
and gradual dynamics in the epidemiology (Chow et al. 2005).Research on CAPD peritonitis 
shows signs of decreasing trends in the Gram-negative pathogens (Vikrant et al. 2013). 
Different patterns of the microbiological organisms associated with peritonitis show variations 
between the developed and developing countries. Developing countries are the worst affected 
because of different risk factors such as poverty, environmental degradation, education levels 
and climate change (Dunkle et al. 2013; Goldstein et al. 2013; National institute of 
health.2006). Research conducted in Australia and Europe when compared to studies done in 
Asian and Latin America, shows discrepancies in causative micro-organisms involved in 
CAPD peritonitis in the different regions (Troidle et al.1998; Dunkle et al. 2013; Piraino et al. 
2003). However, African countries seldom have official registers or reports of the number of 
dialysis patients and organisms that result in complications (National institute of health.2006). 
However there is evidence of African countries using simple and cheap tests for diagnosis and 
treatment to delay complications of kidney failure. Levey et al. (2007) argues that translating 
these advances to simple and applicable technologies to be adopted in public health facilities 




Continuous Ambulatory Peritoneal Dialysis modality of treatment of CRF is one of the easier 
methods of treating CRF due to its practicability. CAPD is a relatively easy treatment method 
since it doesn’t require needles or complicated equipment, on the down side; patients can 
develop peritonitis (Canusa.1996; Kerschbaum et al. 2013). This infection is caused by 
microorganisms (gram positive bacteria, gram negative bacteria, fungi, and to some extent 
viruses). These are isolated in the peritoneal fluid during infection and play an important role 
in the outcomes of the different types of dialysis modalities, this complication remaining a 
burden among CAPD patients (Vikrant et al. 2013; Prasad et al. 2007). In Africa, some patients 
contract peritonitis within the hospital. The microorganisms associated with peritonitis are 
nosocomial and they usually develop resistance towards the first line antimicrobial agents 
which are more affordable than the second line that are costly for most of African countries.   
The dearth of research on the incidence and cost burden of peritonitis leads to neglect of the 
condition by stakeholders such as policy makers and multinational organisations that deal with 
health issues. Chertow et al. (2005) conducted studies from which the results showed that 
Chronic Renal failure (CRF) is not only a significant public health burden but also a major cost 
driver of medical expenses worldwide. Levey et al. (2007) noted that the prevalence of CRF 
amongst non-institutionalised adults in America and Europe was as high as 9.6% of the 
population. A study in Boston, conducted by Chertow et al. (2005) noted that CRF was 
associated with 6.5 fold increases in odds of death, a 3.5 increase in length of stay (LOS) in 
medical institutions and about $7500 in excess hospital costs .Thus research from developed 
countries show the burden of CRF, but the situation is vaguely understood in the African 
context. CRF that occurs at the End Stage Renal Diseases, are a serious burden for both the 
patients caregivers and health care professionals, especially in the public service (Okpechi et 
al.2010). There is evidence to suggest that peritonitis possess as a problem in the public health 
sector in South Africa, hence need to understand its prevalence and dynamics in order to 
develop effective management guidelines.  
 
A study conducted by Abu-Aisha et al. (2010) found the prevalence of patients on CAPD in 
South Africa was 3660 in 2007. The highest prevalence of patients on CAPD was found in the 
province of KwaZulu-Natal. However, Abu-Aisha’s study focused on country level records 
and this study sought to investigate the incidences of peritonitis at the micro-level.  In order to 
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achieve a micro-understanding of CAPD and peritonitis the study took a case study Inkosi 
Albert Luthuli Central Hospital in KwaZulu-Natal. The hospital is the highest ranked public 
hospital according to the South African government rankings. On clinical impression, our 
experience at Inkosi Albert Luthuli Central Hospital (IALCH) Durban, the microbiological 
spectrum of peritonitis during CAPD is changing among poor patients in South Africa, a 
country with a high prevalence of HIV1 (Mujais et al. 2006). IALCH is the one of well-
equipped tertiary hospital without valid information about the burden of infections for 
managing patients on CAPD using evidence based knowledge. Therefore, the objective of this 
study is to estimate the incidence of peritonitis and to describe the types of microorganisms 
related with peritonitis amongst CAPD patients according to gender, age, ethnicity, months, 
microbiological culture, severity of renal failure, treatment. 
 
Having an overview of the commonest microorganisms involved in peritonitis might be a 
helpful tool to suggest syndromic treatment guidelines while awaiting the susceptibility results 
from laboratories for adequate management. This may prevent and avoid emerging resistant 
strains of microorganisms due to inappropriate use of antimicrobial drugs. There are many 
cases of emerging resistances among CAPD patients; however there is dearth of knowledge on 
this condition in KZN. 
 
1.2 The Problem statement 
Bacteria and fungi are the leading cause of peritonitis in adults and children undergoing CAPD 
(Vas et al.2001). Peritonitis has been associated with patients undergoing CAPD resulting in 
complications of their conditions. Furthermore, there is growing evidence that demonstrate the 
microbiological spectrum of patients are different depending on region and are showing signs 
of changing (Dunkle et al. 2013). Management of CAPD peritonitis has been dependent on 
laboratory tests and simple technologies which are expensive for developing countries like 
South Africa to adopt throughout all public hospitals. The poor understanding of 
microorganism responsible for peritonitis amongst CAPD patients might result in complication 
or even possibly death. In order to reduce complications amongst patients, clinical indicators 
                                                          
1 According to Human Sciences research Council’ s 2012 report, the national HIV prevalence 




could help earlier response by clinicians while awaiting laboratory results. The complexity of 
the diagnosis and management of CAPD peritonitis falls is experienced in the background of 
resource poor facilities and the large burden of CAPD patients in the KwaZulu-Natal province. 
Hence the study sought to explore the prevalence and socio-demographic characteristics that 
predisposes CAPD patients to microbiological organisms associated with peritonitis at Inkosi 
Albert Luthuli Central Hospital.  
 
1.3 Research Questions 
1. What were the prevalence and microbiological   features of peritonitis in CAPD patients 
at IALCH. 
2. What were the demographic factors and clinical factors associated with the 
development of peritonitis in CAPD patients in our settings? 
 
1.4 General and Specific Objectives 
The study sought to establish the nature and extent of peritonitis amongst CAPD patients at 
IALCH in Durban 
Therefore, the specific objectives of this study were: 
1. To establish the prevalence of CAPD peritonitis. 
2. To establish  the socio-demographic predictors  and clinical predictions of CAPD 
peritonitis 
3. To describe the types of peritonitis microorganisms in CAPD patients 
4. To make recommendations to clinicians and other health stakeholders 
 
 
1.5 Layout of research report 
This research is presented in five Chapters, which present the thesis of the study. 
Chapter zero will present the Abstract. 
Chapter one will present the introduction to the dissertation in the following sections; the 
background of the study, statement of the study, research questions, objectives and the structure 
of the dissertation. 
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Chapter two will present the literature review chapter. The literature review of this dissertation 
reviews literature on the following issues: peritonitis dialysis; microbiology of peritonitis; 
cultural and laboratory diagnosis; empiric treatment and drug dosing and stability.  
Chapter three will describe the study area, sampling techniques, data collection and analysis 
techniques used.  
Chapter four will present results of the research. Data presented will be on: the incidence of 
peritonitis; microbiological organisms associated with CAPD peritonitis and socio-
demographic data of the patients. 
Chapter five will present the discussion of the results reflecting on the literature, methodology 




Chapter 2: REVIEW OF THE LITERATURE 
 
2.1 Introduction  
This chapter reviews the literature relevant to this study, and addressed how Peritoneal Dialysis 
works; diagnosis and management of peritonitis. The literature reviewed in this chapter mainly 
draws from case studies from the developed world and little from African countries due to 
literature gap in Africa.   
  
2.2 Peritoneal Dialysis  
 Kidney failure can lead to uraemia and insufficient excretion of other substances that are 
normally excreted in the urine. This results in a blood pressure increase, oedema, anaemia, 
osteoporosis due to kidney failure. The most common treatment options for kidney failure are 
peritoneal dialysis (PD) and specify haemodialysis, with the latter using an extracorporeal 
blood circuit to free the blood of waste. 
 
CAPD removes toxins by entering the abdomen, with a catheter being permanently placed in 
the peritoneal cavity and connected to a bag that contains the dialysis solution (National 
institute of health.2006).The peritoneum membrane plays the role of removing waste from the 
blood into the dialysis solution, which will be drained and exchanged, according to the schedule 
time. 
There two types of PD: 
• CAPD is the main type used at IALCH, is less complicated than dialysis as it does not 
require a machine, and the patient can manage their treatment easier. 
• Continuous Cycler Peritoneal Dialysis (CCPD) or automated peritoneal dialysis requires 







Figure 2.1: The normal CAPD set up  
Copied image from National Institute of Diabetics and Digestive and Kidney Disease (National 
institute of health. 2006). 
 
2.3 Microbiology of Peritonitis 
The improvement in connecting catheters, exit site cleansing, and the topical management of 
Staphylococcus aureus have contributed to the decline of peritonitis (Zelenistsky et al. 2000; 
Piraino et al. 2003). Literature shows that the microbial distribution in peritoneal dialysis 
population is consistent amongst many dialysis centres, even though minor disparities may 
exist (Schaefer et al. 2007). The International Paediatric Peritonitis Registry (IPPR) data shows 
homogeneity in the microbiological organisms associated with peritonitis in adults and 




Data from IPPR on 501 episodes of peritonitis from the period of October 2001-December 
2004 has shown 392 occurrences of peritonitis in children in whom 10% were caused by fungi, 
44% by gram positive bacteria, and 24% by gram negative bacteria and culture negatives in 
31% of cases (Fig. 2.2).  Even though these findings  support the decrease of gram positives ; 
their species differ from the study conducted by Mujais et al. (2006), in a survey of more than 
4000 episodes peritonitis in adults patients from the USA and Canada. 
 
 
Figure 2.2: Distribution of causatives organisms among 501 episodes of peritonitis reported by 
the IPPR copied from Warady et al. (2007). 
 
Furthermore, there is variation in the distribution of organisms among the different regions of 
the world (fig 2.3). The bacteriological profile differs from region to region according to IPPR 
data. Hence, making it difficult to predict the causative organisms involved in peritonitis, since 
they vary depending on geography and environmental variability across the World (Szeto et al. 
2003). European countries were dominated by the occurrences of gram positives: Eastern 
region with coagulase negative Staphyloccocus and Staphylococcus aureus in the western 
region (Mujais et al. 2006). In Turkey and Mexico, culture negatives were found in 42% and 






Figure 2.3: Distribution of causative organisms according to the regions among 501 episodes 
of peritonitis reported by the IPPRU: Copied from Schaefer et al. (2007). 
 
Yeasts, mainly Candida species are the most common fungal organism associated with 
peritonitis, Diphteroids species are associated with skin contamination, and viruses are not 
among the peritonitis causatives organism. 
 
Tuberculosis is one of the conditions that are identified in the literature as being responsible 
for complication of patients on CAPD. M. tuberculosis an intracellular microorganism that 
affects the cellular immune system among the CAPD patients who are already immune-
compromised (Warady et al. 2007; Goldie et al.1996; Chadha et al. 2010). 
 
Some technical drawbacks such as insufficient effluent volumes, transplantation in rural areas, 
transportation, temperature variation, manipulation of icodextrin solution for PD may impact 
the culture results (Martis et al. 2005). Yet as the culture of the PD is important for the rest of 





Literature demonstrates the peritonitis routes include: touch contamination, tunnel infection, 
enteric haematogenous, and ascending via vagina (Chadha et al.2010). Scholars attribute 
Coagulase negative Staphylococcus (CoNS) as resulting from touch contamination of the 
peritoneum in all the cases (Vas et al. 2001; Piraino et al. 2000). Its incubation period is 
between 24 -48 hours, and the same organisms is associated with the recurrent peritonitis due 
to biofilm, the impression that the decrease in gram positive organisms is mainly due to the 
management of this organism (Chadha et al. 2010).  In the literature it is well known that CoNS 
are among the most encountered Gram positives microorganisms that are isolated in CAPD 
patients.  
 
There are a number of routes that have been documented as responsible for peritonitis in CAPD 
patients. Scholars describe Staphylococcus aureus route as emanating tunnel /exit site 
contamination, and research ranks Enterococci spicies and Streptococcus species are among 
the very fewer causes of CAPD peritonitis (Vas et al. 2001; Piraino et al. 2000). Peritonitis 
caused by Enteroccocus sp, a gut normal flora  suggesting trans mural  infecting route, and are 
also accompanied by the emergence of Vancomycin  resistant  strains  ,making them  very 
dangerous bug that maybe accompanied by a high rate of morbidity (Troidle et al. 1996;Von 
Baum et al.1999). 
 
There are many Gram negative bacilli, that are involved in CAPD peritonitis and their 
acquisition varies according to the contamination. The enteric bacteria detection and multiple 
gram negative detection are strongly suggestive of faecal intra-abdominal contamination 
respectively whereas Pseudomonas and Stenotrophomonas species (spp) are among the 
Multidrug resistant bugs suggestive of Catheter and /or tunnel contamination (Warady et al. 
2012; Zurowska et al. 2008). The biofilm is formed by the organism on the catheter preventing 
antibiotic effect; therefore the removal of the catheter is the first step towards effective infection 
management (Zurowska et al. 2008; Warady et al.1999). Acinetobacter species are non-
fermented micro-organisms are mostly in relation with environment, soil and water 
contamination (Alflaiw et al.1999). 
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2.5 Empiric diagnosis of peritonitis 
The International Society for Peritoneal Dialysis (ISPD) has drawn up a quick diagnosis for 
peritonitis in both children and adults. According to ISPD an empiric diagnosis can be made to 
determine peritonitis by using clinically presented signs and symptoms (America FMCCN. 
2010).These signs and symptoms include: The cloudiness of effluent and abdominal pain 
(which can range from mild to severe according to the causative organism). The severity of 
pain can be related to specific organisms (mild pain with Coagulase Negative Staphylococcus 
(CoNS), and severe pain with gram-negative rods, Streptococcus sp, and Staphylococcus 
aureus). The effluent cell count with differential should be obtained, and if after 2 hours of 
dwell time, the  white blood cell count (WBC )≥ 100/µL with the minimum of half being 
polymorphonuclear neutrophil cells (PMN) is suggestive of inflammation. The Gram stain is 
important in defining the presence of yeasts, differential diagnosis initiative is important to 
exclude other surgical diseases beside peritonitis (America FMCCN. 2010). 
2.6 Culture and Laboratory Diagnosis 
Getting the proper microbiological culture is mandatory to identify the causative organism, to 
perform antimicrobial sensitivity testing, and subsequently to commence the appropriate 
treatment in South Africa. Most of the peritonitis causative organisms can be grown in the 
traditional cultures media using the standard culture technique. The outcomes of culture are 
expected within three days to initiate the appropriate treatment. Failing to establish the 
diagnosis through culture results within three days, may lead to the subculture of miscellaneous 
and slow growing organisms. 
2.7 Treatment 
The specimens are collected prior to initiation of any antibiotic; the preferred route of 
administration of drugs is intra-peritoneal. The treatment option for gram positive bacteria 
options are, vancomycin, or cephalosporin. Gram- negative bacteria are Aminoglycosides or 
third generation cephalosporin, for yeasts, fluconazole is the first choice. Once the culture 
results are known, it is recommended to shift from the empiric treatment to a narrow spectrum 













Figure 2.5 Culture results. Copied   from Li et al. (2010). 
 
2.7.1 Gram Positive  
In general, penicillin derived agents are used as the first line to treat gram positive bacteria.   
Among the leading causes of contamination Coagulase negative Staphylococcus, 
Staphylococcus epidermidis is another gram positive that is involved in CAPD peritonitis, with 
vancomycin, rifampicin and teicoplanin being the drugs of choice. Peritonitis caused by 
Streptococcus and is treated by ampicillin; risk factors are associated with peritonitis caused 
by vancomycin-resistant enterococcus (VRE).  Ampicillin may be used for VRE if it is 
susceptible, and linezolid, quinupristin/dalfopristin, and daptomycin are alternative choices. 
Corynebacterium is a normal skin flora and may be difficult to be considered as a pathogen.  




2.7.2 Gram negative  
Pseudomonas aeruginosa is one of the causes of severe peritonitis, and associated with a 
catheter infection. The eradication of Pseudomonas aeruginosa is very important to avoid the 
shift to haemodialysis. Klebsiella species, E.coli, Proteus species are other causative organisms 
and are also implicated to the biofilm formation (fig 2.6). Stenotrophomonas is another 
causative agent which can be treated by administering thrimethoprin /sulfamethoxazole. 
 
 




Antibiotics must be continued for two weeks while the patient is on HD, however, the duration 
of antibiotic therapy following catheter removal and timing or resumption of peritoneal dialysis 
may be modified depending on clinical course, Trimethoprim and Sulfamethoxazole. 
 
2.8 Polymicrobial, fungal and culture negative peritonitis 
Anaerobes are the cause of this type of peritonitis, and mainly come from contamination 
through the infections of the catheter. Removal of the catheter is part of the resolution for this 
infection. These mixed microorganisms have a superior prognosis in comparison to the 
multiple enteric organisms with the latter evolving intra-abdominal source like diverticulitis, 
ischemia bowel, cholecystitis or appendicitis. The combination of metronidazole, with 
ampicillin, and aminoglycosides have shown efficacy against anaerobes. 
 
As the consequence of multiple antibiotic treatments, the fungal peritonitis results in a high 
incidence of death.  The treatment ranges from fluconazole, flucytosine for the empiric 
treatment of Candida species, to amphotericin B, caspofungin, anidulafungin and micafungin 
are recommended for Aspergillus.  Different combinations are recommended like casposfungin 
and Amphotericin B, Echinocandin, fluconazole, voriconazole or posaconazole may replace 
Amphotericin after culture and sensitivity results.  The use of azole is recommended only after 
culture and sensitivity results, due to the high rate of resistance emerging. Antibiotic use must 
be monitored to avoid the fungal peritonitis as a complication of antibiotic mismanagement. 
 
Culture –negative peritonitis rates is the source of reviewing cultures methods and also 
introduction of new methods to optimize the diagnosis of a typical peritonitis like 
Mycobacterium tuberculosis, yeasts, Legionella sp, Campylobacter, slow-growing bacteria, 
enteric viruses, Mycoplasma, Ureoplasma. Certain clinical conditions, such as hypotension, 
sepsis, lactic acidosis, and elevation of peritoneal amylase may be considered threatening and 
may lead to surgical peritonitis. IP amphotericin B is one of the causes of chemical peritonitis, 






Figure 2.7 Polymicrobial, fungi or culture negative. Copied from Li et al. (2010). 
 
2.9 Drug dosing and Stability 
Aminoglycosides, vancomycin and cephalosporin are among the drugs that can be added to 
one dialysis solution bag by observing strict infection control measures, each being applied 
with a different syringe. The chemical incompatibility is seen between penicillin and the 
aminoglycosides. There are some studies suggesting the modification of dialysate composition 





The possibility for those antibiotics being stable for a long period of time has not been proven, 
and more research is therefore needed to identify the optimal stability conditions for dialysis 
solutions. Substances such as Icodextrin, once introduced in dialysis solutions, are compatible 
with drugs such as vancomycin, ampicillin, cloxacillin, ceftazidime, gentamycin and 
amphotericin B, with opposition to heparin that impact in stability. 
 







Vancomycin 25mg/l 28 RT 
Gentamycin 8mg/l 14  
Cefazolin 500mg/l 8 RT 
Ceftazidime 200mg/l 10 Refrigerated 




Intermittent or Continuous Dosing of Antibiotics: Special considerations for APD: 
Intraperitoneal (IP) is better than intravenous (IV) dosing. IP can be performed by the patient 
at home after proper training, to avoid the venepuncture needed for IV access and the dwelling 
of antibiotics lasts at least 6 hours allowing adequate absorption.  For both APD and CAPD 







Dosing  of drugs in patients with residual renal function (defined as>100mL/day urine 
output),should be empirically increased by 25%,Vancomycin should be re-dosed if serum 
through levels fall below 15 µg/given in conjunction with 500 mg quinupristin/dalfopristin 
intravenous twice daily. CAPD loading dose (LD). Maintenance dose (MD). 
 
Table 2.2 Peritoneal dialysis and recommendations regarding related infections. 






2.10 Refractory, Relapsing, Recurrent, and Repeat Peritonitis  
According to the 2010 ISPD Guidelines, the following definitions are acceptable and applied 
in CAPD practice: 
a. Refractory peritonitis: occurs when after five days of appropriate anti-biotherapy there is 
a failure of the effluent to clear. 
b. Relapsing peritonitis: any episode occurring within four weeks of completion of therapy 
of a prior episode with the same organism or one sterile episode. 
c. Recurrent peritonitis: any episode with a different causative organism occurring within 4 
weeks of completion of therapy of a prior episode 
d. Repeat peritonitis:  any episode that occurs within a period of more than four weeks after 
completion of therapy of a prior episode with the same organism. 
Recurrent, relapsing and repeat peritonitis are associated with worse outcomes, and as a 
palliative method of treatment, catheter removal should be performed in an optimal period of 
time. 
 
2.11 Patient Education 
It is essential for any patient to undergo the PD education by suitable trained personnel such as 
a nurse. It should cover the following: any symptoms of abdominal pain, cloudiness of effluent, 
or fever, the dialysate fluid must be drained and sent for analysis to the laboratory.  In addition, 
the patient should be prepared to understand that the treatment lasts a minimum of 3 weeks, if 
no clearance of the fluid the patient should report. 
 
Several studies have shown discrepancies among the causative gram negative (GN) and gram 
positive (GP) organisms in CAPD   peritonitis patients across the world making this 
complication a very serious public health problem contributing to occasional disability 
amongst many patients who are part of the active population group and therefore affecting the 
Economy severely affected countries. This trend varies in different countries but the economics 




 In 2012, Lioussfi et al. conducted a study from which data were collected between 2006 -2009 
and found that among adult patients who are aged between 19 and 78 years (mainly male) their 
onset period from dialysis commencement was 7.9±8 (1-29) months. Their findings were in 
contrast with documented trends of causative microorganisms in CAPD patients. They found 
that gram negative were found in 55% vs 45% of gram positive microorganisms. In another 
study conducted by Nessim  et al. (2011) that used data from the  Canadian multicentre Baxter 
Poet (peritonitis, organisms Exit Sites, Tunnel  infections) it showed that between 1996 and 
2005, the large proportion of patients with 2 or more were caused by the same organisms. Their 
findings suggested that out of 558 patients, 181(32%) had at least 2 episodes with the same 
organisms, and in addition  to their findings ,the organism commonly associated with the 
occurrence of  repeat infection was Coagulase negative Staphylococcus, accounting for 65.7% 
of cases vs. peritonitis caused by other organisms (Lioussfi et al. 2012). 
 
A first Coagulase negative Staphylococcus peritonitis was associated with an increased risk of 
subsequent Coagulase negative Staphylococcus peritonitis within 1 year (odd ratio: 2:1.955) 
confidence interval: 1.5 to 2.8, p<0.0001). Among patients with repeat Coagulase negative 
Staphylococcus peritonitis, 48% of repeat episodes occurred within 6 months of the earlier 
episode. Their   findings are in contrary to those of Lioussfi et al. (2012).  
Nessim et al. (2011) demonstrated also that males were more vulnerable than females, and also 
among the predictor causes for CAPD peritonitis, diabetes mellitus was a leading comorbidity 
followed by Hypertension and Glomerulonephritis. Other studies have focused on how socio-
demographic characteristics influence one’s susceptibility to peritonitis. Mehrotra et al. (2011) 
analysed the relationship of selected patient’s socio-demographic profile by focusing on 
geographical location specifically comparing incidences of peritonitis in rural and urban areas. 
In the United States of America it was observed that there are significant regional differences 
in the outcomes of PD amongst patients from ‘country sides’ (rural) and those from urban areas. 
Understanding the differences in clinical practices that underlie these regional differences 
might help to further improve PD outcomes. In another case, a multicentre observational study 
conducted by Martin et al. (2011) from 2004 through 2007, concluded that clinical dialysis-
related with demographic, and socioeconomic variables. Patients were followed up until the 
first peritonitis. The Cox proportional model was used to determine independent factors 
associated with first peritonitis. The results of 2032 patients were that 474(23.3%) presented a 
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first peritonitis episode. Their findings demonstrate that lower levels of education, on-white 
race, region where patients live affect their risk. 
Lo et al. (2012) reported 9 cases of exit –site infection in China and CAPD peritonitis 
associated with atypical mycobacteria. All patients have been using topical gentamycin cream 
as prophylaxis for exit-site infection before the onset of these infections. Gentamycin cream is 
postulated to be potential risk factor for a typical mycobacterial infection because of selective 
pressure on their microorganisms. The microbiology of atypical mycobacterial infections is 
discussed.Yap et al. (2012) in a retrospective study from 1995-2010 found that, the overall rate 
of peritonitis was low after contamination. Wet contamination was associated with a much 
higher risk of peritonitis prophylactic antibiotics after wet contamination were effective in 
preventing the occurrence of peritonitis, this contrasting with a study conducted by Lo et al. 
(2012). A cohort study by Dong et al. (2013) demonstrates that gram positive coagulase 
negative staphylococcus organisms are a leading cause of CAPD peritonitis. This is an issue of 
concern among the health professional due to its unpredictability with regard of causatives 
organisms. These results are in a contradiction to those of Lioussfi et al. (2012).Increasingly 
scholarship is studying the relationship between peritonitis and climatic factors (Cho et al. 
2013; Chan et al. 1983). In one of the early studies on the link between peritonitis and climate 
Chan et al. (1983) examined the relationship of all the episodes of peritonitis in CAPD patients 
to climatic factors, such as temperature and relative humidity. Such early studies are important 
for prioritising the role of climate factors to understanding the features and dynamics in 
peritonitis. In a more recent study in Australia, Cho et al. (2013) demonstrated that the impact 
of climatic variations on peritoneal dialysis PD-related peritonitis has not been studied in detail. 
In their retrospective study they considered influence of climate, and climatic regions were 
defined according to the Koppen Classification. The overall peritonitis rate was 0.59 episodes 
per patients –years. Most of the patients lived in temperate regions (65%), with others residing 
in the following regions: subtropical (26%); tropical (6%); and other climatic regions (desert 
1%, Grassland 2%). Compared with patients in temperate regions ,those in tropical regions 
demonstrated significantly higher overall peritonitis rates and a shorter time to a first peritonitis 
episode[adjusted  hazard ratio: 1.15;95% confidence interval: 1.01 to 1.31]. Culture negative 
peritonitis was significantly less likely in tropical regions [adjusted Odd Ratio: 0.42; 95%CI: 
0.25 to 0.73], but its occurrence in subtropical and other regions was comparable to that in 





Fungal peritonitis  was independently associated with tropical regions (OR:2.18;95%CI1.22 to 
3.90) and others regions (OR:3.46;95%CI:1.73 to 6.91) rates  of antifungal prophylaxis were  
lower. Outcomes after first peritonitis episodes were comparable in all groups. Their 
conclusions were that tropical regions were associated with higher overall peritonitis rates 
(Including fungal peritonitis) and a shorter time to a first peritonitis episode. Increasing 
peritonitis prophylactic measures such as antifungal therapy and exit-site care should be 
considered in PD patients residing in tropical climates.In Sweden, Pihl et al. (2013) have 
demonstrated the extend in which bacteria are presents on catheters from PD patients without 
clinical signs of infection. The bacteria were detected on 12 of the 15 catheters from patients 
without signs of infection. Single-species and mixed microbial communities containing up to 
5 species were present on both the inside and the outside along the whole length of colonized 
catheter. Stinghen et al. (2007) demonstrated that the peritonitis rate and patterns show a 
consistent variation that mirrors geographic location in relation to the health centre influences 
the progression of peritonitis. For instance, the distance from a PD centre and weather 
characteristics represent geographic risks factors that are linked to peritonitis characteristics 
and particularly to clinical outcomes. Their study revealed that co morbidities and others 
factors influencing the selection of dialysis modality showed that patients  living  more than 30 
miles (48 kms) from  the  nearest dialysis centre had significant  higher odds of being 
prescribed. 
According to the study conducted by  Mizumasa et al. (2013) ,their findings  revealed that 
submesothelial connective tissue thickness was significantly greater  in the Diabetes Mellitus 
group  than in the non-DM group (p<0.0001). Based on the multivariate linear regression 
analysis, diabetes was identified as a significant independent variable of both submesothelial 








In the introduction it was discussed that socio-demographic, environmental, contamination and 
features of microbiological organisms shape the incidence and complexity of peritonitis. The 
literature review in this chapter demonstrates that these factors have been alluded to as being 
linked to peritonitis. Literature reviewed in this chapter shows that incidence rates are known 
in the developed countries like USA and Europe. By contrast very little is known about the 
incidences of peritonitis in Africa except in a few countries were case specific studies have 
been carried out. Furthermore literature reviewed demonstrates how micro-organisms 
associated with peritonitis are influenced by climatic conditions resulting in different species 
being responsible for the condition in different regions. Hence the need to understand features 





CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Introduction 
In order to address the objective presented in chapter one the study adopted a quantitative 
methodology that is informed by positivism. The study adopted a retrospective case-control 
approach that involved drawing data from medical records of patients (cases) who underwent 
CAPD treatment and developed peritonitis and those who did not were recruited. This chapter 
will present the study location and its attributes first. Then the chapter will present the sampling 
techniques used including the criteria for population selection. Thirdly, the chapter will present 
the data collection method and its justification. Finally, the chapter will present the data 
analysis techniques. 
 
3.2 The Study Area 
The study was conducted at Inkosi Albert Luthuli Central hospital,   Durban, situated in the 
KwaZulu-Natal province, South Africa. KwaZulu-Natal is located on the eastern part of South 
Africa, stretching along the eastern coast of the Indian Ocean. The province has a population 
of 10.3 million people according to the 2011 census (Beck. 2013). The province is a multiracial 
community comprising mainly of: blacks, whites, Indians and other minor ethnic groups. 
Durban is the biggest city in the province.  
 
Amongst all the public hospitals in the province Inkosi Albert Luthuli is the biggest and the 
only one endowed with all available specialised services in the province.  As a public health 
facility, the patients admitted to the dialysis unit are referred from hospitals across the province.  
These patients are unable to afford private health care and rely on public health services to 
meet their health needs. Patients admitted to unit are those in end stage of renal failure, who 
have not been able to secure a kidney transplant, but whose chances of survival with dialysis 
are good.  This includes those who are HIV positive which were not selected and qualified for 






3.3 Sampling Framework and the Definition of study population 
 
Inkosi Albert Luthuli Central Hospital was purposively sampled since the special services 
including PD are conducted at the institute. Furthermore the researcher was working at the 
institution and resided in Durban. As it was a retrospective review, it was not possible to decide 
on an optimal study size, but rather all participants who met the inclusion criteria would become 
the study sample. The following inclusion and exclusion criteria applied for the case and 
control groups:  
a. Cases:   
Inclusion criteria:  
• All the patients with End Stage Renal Disease (ESRD), attending IALCH,  
• Those who underwent CAPD treatment and developed peritonitis between 2009 
January 01- 2010 December 31. 
Exclusion criteria: 
• All the CAPD patients who developed other type of infection than peritonitis. 
b. Controls:  
      Inclusion criteria:  
• A selection of 2 first CAPD patients with no history of peritonitis that attended 
each clinic during the study period. 
            Exclusion criteria: 
•  The following exclusion criterion was used:  
• Patients who regularly attended the clinic but were lost to follow up. 
 
 
3.4 Data collection tools 
A data collection sheet was developed as a data collection tool. The tool was developed to 
collect the following data from the patient’s records:    
Demographic details:  
• age, 
• gender,  
• race , 
• residence (urban/rural) 
• medical history:  
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• time of onset, 
• obesity,  
• hypertension,  
• diabetes mellitus,  
• other underlying factors 
• serum creatinine  
• erythrocyte sedimentation rate (ESR),C-reactive protein (CRP),initial treatment 
modality  
• Microbiological culture types of pathogens, treatment duration: the time between 
the starting date and cessation date. 
 
The abnormalities were defined by, ESR≥100, PDF≥1140, and Creatinine≥750. Seasonality 
included variations of months and winter in Durban (June to August), summer (between 
September and April), winter is between autumn (mid-February to April) and springs (August-
mid October). 
The laboratory staff has a standardised method of collection of samples and processing. The 
data captured on the patient charts followed the Department of Clinical Microbiology/ National 
Heath Laboratory Service standard operating procedures. The diagnosis of peritonitis was 
determined by using the following criteria: Abdominal pain, peritoneal fluid containing more 
than 100 white cells/ ml with at least 50% polynuclear cells, and the pathogens in the peritoneal 
dialysis fluid (Warady et al. 2007). The standard microbiological test (culture) consisted of the 
pathogens being isolated from peritoneal dialysis fluid (PDF) and cultured on standard media 
agar plates for three days, and for fungi on Sabouraud agar, anaerobes rods are not cultured in 
IALCH laboratory.  
 
We conventionally use mixed anaerobes organisms to express the multiplicity of infection and 
culture of anaerobes is expensive we don’t routinely culture anaerobes in our laboratory and 
we use partial identification based on microscopic morphology appearance.  In this study other 
organisms’ refer to those who are not usually isolated in our   laboratory. 
  3.5 Data Analysis 
The researcher with the help of a research assistant extracted the data from the hospital patient 
register computer frame. The data was manually entered on to the data collection sheets. The 
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data on the sheets was coded and entered into a computer package called the Statistical Package 
for the Social Sciences (SPSS version 21, IBM incorporated Chicago, IL, USA). The 
demographic data was analysed using descriptive statistics: sum, mean, average and presented 
in tables and graphs. As presented above the study collected socio-demographic data and it was 
split into categories for easier analysis. Data on the age (in years) of patients was categorised 
into three age groups namely less than 35 years was the first, 36-50 years was the second and 
then finally above 51years.. Data on race was disaggregated into four categories namely: 
blacks, Indians, Coloureds and Whites. Data was also disaggregated by gender and if is referred 
to as female or/and male. Data was also disaggregated using the area of residency of the patient 
and this data was analysed as either rural or/and urban.  
 
Cox proportional hazards was performed to estimate hazards ratios (HR) with corresponding 
95%CI for the occurrence of new onset of CAPD peritonitis associated with the variables of 
interest. In risk stratification analysis, we divided participants into exposed (presence) and non-
exposed (absence) arms 
Differences between exposed and non-exposed arms were assessed, and Kaplan-Meier survival 
curves generated for each arms. The differences between arms were analysed by log rank, chi-
square or t test as appropriate. 
Data were expressed as means ± standard deviation (SD) for continuous variables and 
proportions (%) for categorical variables.  Percentages across group were compared using chi-
square test.  Means values between two groups’ ≥3 groups were compared using t student test 
and analysis of variables (ANOVA), respectively.  The P Value of <0.005 was considered 
significant different in statistical parameters.  Univariate and multivariate logistic regression 
analysis were performed using statistical package software for social sciences (SPSS) version 
21.0 for windows (IBM*Incorporated) Chicago, IL, USA.  
 
3.6 Ethical consideration 
The study observed ethical codes of conducting medical research. The study was ethically 
cleared by the University of KwaZulu-Natal REF: BF190/010 (UKZN) ethics office and the 
Biomedical Research Ethics committee. Data were manipulated using the IALCH Speed miner 
Software to access the medical records of our sample patients. All names or any other 
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information that could lead to linking the data and the patient was removed before data analysis. 
Thereafter, the manager of the data was contacted and an appointment made for the researcher 
to have access to the patient charts.  The researcher printed out the data collection sheets and 
sat at the computer in the records department to access the relevant files. 
 
All the data collection sheets were kept in a locked cupboard in the researcher’s office, and the 
digital data was only accessed on a password protected computer.  Only the researchers, the 
statistician and the supervisor had access to the raw data. The data will only be disseminated 
as aggregated information at various forms, as well as made available in publications.  
 
3.7 Summary 
Chapter four has presented the research methodology, sampling framework, data collection 
tools, data analysis and ethical considerations. The study is dominantly quantitative and utilises 
data collected from the patient’s charts. Only patients on CAPD were included in the study 
since the study aims to address issues around peritonitis. CAPD peritonitis patients formed the 
experiment population while the rest formed the control group. The two groups were not 
statistically drawn since it depended on the condition of the CAPD patients who presented 
themselves to IALCH, Durban. Both descriptive and analytical data analysis techniques were 
used to varying degrees depending on the research question to be answered. Finally, high levels 
of ethical conduct were observed throughout the research process including the entry, data 
collection process and the exit.  
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CHAPTER 4: RESULTS 
 
4.1 Introduction 
This chapter presents the study results that address the study objectives. The objectives set out 
in chapter one stipulates that the study address the following issues: explore socio-demographic 
characteristics of CAPD patients; establish the prevalence of peritonitis; and to describe the 
microbiological organisms associated with peritonitis. The chapter will establish the patient’s 
socio-demographic data first, then, clinical prediction. Finally, the incidence and features of 
micro-organisms associated with peritonitis are presented last. 
 
4.2 Results  
Between January 2009 and December 2010, 115 patients underwent CAPD of which 91 
patients met the inclusion criteria. Amongst the 91 patients recruited in the study, 45 (49%) 
presented with peritonitis (cases) and 46 (51%) did not have peritonitis (control) (Table 4.1). 
The results presented in Table 4.1 indicate that out of 45 CAPD patients with peritonitis, 24 
(53.3%) were Indians, followed by 18 (40%) blacks, 2 (4.4%) coloureds and 1 (2.2%) white. 
Of the 45 participants diagnosed with peritonitis, 29 (64.4%) and 16 (35.6%) were females and 
males respectively. The Total case and rate of peritonitis in year 2009 were presented and 
analysed as followed: The number of patients’ months= numbers of patient’s day/30.42. 
The overall 100 patients x365 days/30.42=1.19986/30 episodes =39.99=40 months of 
peritonitis free. 
Since in 2009 we had 30 episodes, and only 15 episodes in 2010 which reflect the ½ of the 
episodes observed in 2009.  
Among patients with peritonitis, 93.3% (42/45) were living in urban areas while 6.7% (3/45) 
were residents in rural areas.  The age of the study population ranged between 35-50 years. 
There was significantly more females than males among the cases group (p=0.00466), but no 
significant difference was observed between the two groups (control and cases).  There was no 
significant difference observed between blacks and Indians (p= 0.2048). However, a 
statistically significant difference was observed between both black and Indians when 
compared to either whites or coloured (p< 0.01).Obesity, hypertension, diabetes mellitus were 
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significantly associated with the development of peritonitis (p=0.03, 0.00652, 0.00782, 
respectively). 
Table 4.1 Summary of demographics and Clinical characteristics of CAPD patients with and without 
peritonitis. 
Demographics & Clinical Cases Group Controls Group  
P. value Characteristics No. 45 % No. 46 % 
AGE 
≤35 years 17 37.8% 13 28.3% 0.33204 
35-50 years 20 44.4% 26 56.5% 0.2654 
≥50 years 8 17.8% 7 15.2% 0.1936 
GENDER 
Female 29 64.40% 23 50% 0.16452 
Male 16 35.50% 23 50% 0.16452 
RESIDENCE 
Urban 42 93.30% 39 84.80% 0.1936 
Rural 3 6.70% 7 15.20% 0.1936 
ETHNICITY 
Blacks 18 40% 14 30.40% 0.33706 
Indians 24 53.33% 28 60.90% 0.4654 
White 1 2.22% 0 0% - 
Coloured 2 4.44% 4 8.70% 0.41222 
OBESITY 
Obese 18 41% 34 73.9% 0.003 
Not obese 26 59% 12 26.1% 0.17702 
HYPERTENSION 
HPT 36 80% 45 98% 0.00652 
Non HPT 9 20% 1 2% 0.00652 
DIABETES 
DM 5 11% 20 43.5% 0.00782 




      
GN 16 35.60% 30 65.20% 0.02034 
Others 29 64.40% 16 34.80% 0.02034 
 
During univariate analysis (Table 4.2), there was no association between gender, age, residence and 
ethnicity with the development of peritonitis. However, obesity, diabetes mellitus, and hypertension 
were significantly associated with peritonitis among CAPD patients (Table 4.2).  
 
Table 4.2.  Univariate associations between selected demographics and clinical variables and 
peritonitis in CAPD patients 
Variables Pvalue OD ratio 95% CI Significance 
Age  0.666 1.308 [0.387-4.41] NS 
Gender  0.193 1.750 0.753-4.067 NS 
Residence 0.204 2.571 [0.607-10.405] NS 
Ethnicity  0.205 2.714 [0.434-16-961] NS 
Obesity  0.044 3.763 1.038-13.646 S 
Diabetes  0.013 6.0 1-467-24.547 S 
Hypertension 0.026 11 1.33-90.95 S 
Creatinine 0.037 2.875 1.068-7.742 S 
CRP     
     (* variables with insufficient data were not included in the analysis) 
During the multivariate analysis using logistic regression models, diabetes mellitus, CRP levels ≥ 100 
and black ethnicity were independently associated with peritonitis among CAPD patients (Table 4.3). 
Table 4.3 Independent predictors of the incidences of peritonitis among CAPD 
participants 
Independent 
Predictors  B SE HR95%CI P 
 Diabetes mellitus Yes 0.763 0.359 2.2 (1.1-43) 0.034 
  No  References 1  
 CRP ≥100 1.05 0.379 2.9 (1.4-6) 0.006 
  <100  References 1  
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 Ethnicity Blacks  1.85 0.929 6.4 (1.03-39.3) 0.046 
  Others 0.492 0.359   
      
Table 4.4 confirms the presence of a significant relative risk of peritonitis for diabetic patients when 
corrected for hypertension. (OR = 5.314, p = 0.023). However, the RR of peritonitis associated with 
hypertension was not confirmed after correcting, therefore making HPT a confounder. 
Table 4.4: Correction between hypertension and diabetes associated with development of peritonitis in 
CAPD peritonitis. 
Variables P.value OD Ratio 95%CI Significance 
Diabetes corrected for Hypertension 0.023 5.314 [1.256-22.489] S 
Hypertension corrected for Diabetes 0.532 2.032 [0.220-18.765] NS 
     
The aetiological agents of peritonitis among the cases are displayed in Table 4.5 below. Of 45 cases, 
microbiological confirmation was done in 29 patients. The predominant causative agent was 
Staphylococcus aureus (8 cases) followed by Candida albicans (7 cases), mixed anaerobes (6 cases) 
and Pseudomonas aeruginosa (3 cases).   
Table 4.5. Proportions of isolated micro-organisms from CAPD patients with peritonitis 
Type of microorganisms n (%) 








              Candida albicans 
Rhodotorula species 





                                  9 (31) 
8 
1 
                                     9 (31) 
7 
2 






Table 4.6 displays the susceptibility patterns of the causative agents of peritonitis isolated from 
the study population.  
Table 4. 6: Summary of causatives micro-organisms and antimicrobial sensitivity profile in 
CAPD peritonitis patients. 
Microorganisms Sensibility Resistance Antibiotic prescribed 
Staph aureus Cloxacillin  Protocol 
Staph aureus Cloxacillin  Protocol 
Staph aureus Cloxacillin  Amikacin and ciprofloxacin 
Staph aureus Cloxacillin   Protocol 
Staph aureus Cloxacillin  Protocol 
Staph aureus Cloxacillin  Vanco+cipro 
Staph aureus Cloxacillin  Protocol 
Staph aureus Cloxacillin  Protocol 
Staph epidermidis Vancomycin  Protocol 
Candida albicans Fluconazole  Fluconazole 
Candida albicans Amphotericin B Fluconazole Amphotericin B 
Candida albicans Fluconazole  Fluconazole 
Candida albicans Fluconazole  Fluconazole 
Candida albicans Fluconazole  Fluconazole 
Candida albicans Amphotericin B Fluconazole Amphotericin B 
Candida albicans Fluconazole  Fluconazole 
Rhodotorula spp Amphotercin B  Amphotericin B 
Rhodotorula spp Amphotercin B  Amphotericin B 
Pseudomonas aeruginosa Piperacillin and Gentamycin  Protocol 
Paseudo aeruginosa Meropenem 
Ciprofloxacin 
and amikacin 
Meropenem and ciprofloxacin 




Amikacin and ciprofloxacin 
E.coli 
Gentamycin and amoxicillin 
and clavulanic acid 
 Protocol 
Klebsiella pneumonia 
Piperacillin and tazobactam 





All 8 isolates of S. aureus were susceptible to cloxacillin, a first-line drug of choice used in the 
management of staphylococcal infections in our facility. The only isolate of S. epidermidis was 
however resistant to cloxacillin but susceptible to the second-line vaconmycin. Whilst the 2 
isolates of Rhodotorula spp were resistant to fluconazole, 5/7 isolates of C. albicans were 
susceptible to fluconazole, the first-line antifungal drug used in our facility. All fungi that 
displayed resistance to fluconazole were all shown to be susceptible to amphotericin B. 
Susceptibility profile of P.aeruginosa and other isolated Gram negative bacteria varied and can 
be seen in Table 4.6.   
 
The associations between types of microorganisms and mean levels of serum creatinine, age 
and onset of peritonitis among CAPD patients are depicted in Table 4.7.    








Month of onset 
Mean±SD 
S.aureus 31.6±10.6 1691.5±184.7 8±3 
E.coli 43±14.1 821.5±10.6 4±2 
S.epidermidis 61 970 1 
P.aeruginosa 25±0.01 1379.3±103.3 4±1 
C.albicans 46.9±8 1443.4±417.5 10±3 
Other pathogens 41 1096 2 
Mixed(anaerobes) 33.5±9.2 1510±413.9 6±2 
Negative culture 38.5±12.3 1077.1±407.8 6±3 
ANOVA,P 0.021 0.012 0.040 
 
The mean age of CAPD patients with peritonitis was 37.64 (±10.86) years (Figure 4.1). Among 
patients aged below 40 years, P. aeruginosa, S.aureus and mixed anaerobes were shown to be 
the predominant pathogens (Table 4.7 and Figure 4.2). However, for older patients (> 40 years), 




Figure 4.1 The age distribution of CAPD associated with peritonitis. 
 






































































Figure 4.3 Peritonitis mean of onset (in months) 
The onset of peritonitis among the study population appeared after 19.58 (±17.98) months of 
undergoing CAPD (Figure 4.3). Staphylococcus epidermidis and Rhodotorula species 
(represented as “others”) were shown to cause early onset of peritonitis among CAPD patients 
whilst S. aureus and C. albicans were associated with the late onset of peritonitis (Table 4.7 





Figure 4.4 Onset of peritonitis (in months). 
 
 
Figure 4.5 below shows that the highest level of serum creatinine (>1000) was associated with 
the presence of Staphylococcus aureus, mixed organisms (anaerobes), Candida albicans, 
Pseudomonas aeruginosa, and others pathogens (Rhodotorula spp) as the causative agents for 
peritonitis in CAPD patients. Culture negative samples obtained from patients diagnosed 
clinically with peritonitis were also shown to be associated with high levels of serum creatinine 




















































































Figure 4.5 serum creatinine variations by types of micro-organisms (p <0.0001). 
 
Figures 4.6-10 below describe Kaplan Meir curves and show significant associations between 
age ≥40 years, obesity, CRP, PDF, DM with the occurrence of peritonitis in CAPD patients 

















































































Figure 4.6 Kaplan Meir Curve for relationship between survivals functions and age 
stratification by peritonitis incidence. 
 





Figure 4.8 Association between survival function and the level of peritoneal dialysis fluid count 
(PDF) by peritonitis incidence. 
 
Figure 4.9 Relationship between survival function and levels of CRP by peritonitis incidence 
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CHAPTER 5: DISCUSSION 
 
      5.1 Introduction 
This chapter discusses the study results presented in Chapter 4 and relates them to the literature 
reviewed in focus with the study objectives. The discussion brings together the following three 
components namely: socio-demographic data, medical history, risk factors and incidence of 
peritonitis as well as the associated microbiological organisms.  
5.2.Socio-demographic and risk factors associated with peritonitis among CAPD 
patients 
Findings from this study suggest that diabetes mellitus and black ethnicity were independently 
associated with the development of peritonitis.  These results concur with findings from 
Vikrant et al. (2014) during a study done in India, from a government tertiary care hospital 
where a high proportion of their patients (47%) were diabetics and the mortality was higher for 
diabetic patients than non-diabetic patients. Another Indian study conducted in 2011 by Bunnag 
et al. found that one of the significant  risk factors associated with peritonitis was DM (62.5%) 
in patients with peritonitis within the first years of CAPD as compared to 18.2% of patients 
without peritonitis or had or developed peritonitis after the first year of CAPD (p=0.047). 
A retrospective study conducted by Figueiredo et al. (2013) in Brazil, also found that most of 
their patients were females and DM was a risk factor associated with the development of 
peritonitis. Similar findings were observed in Senegal by Niang et al. (2014).  
The study done by Remon-Rodriguez et al. (2014), suggested that the main comorbidities 
associated with peritonitis among their CAPD patients were diabetes mellitus and 
cardiovascular diseases, particularly hypertension.  
The present study however found that hypertension was significantly associated with 
peritonitis only during univariate analysis. We found that there was a significant relative risk 
(RR) of peritonitis for diabetic patients after statistically correcting for hypertension. In 
contrary, the RR of peritonitis among patients with hypertension was not confirmed to be 
significant after correcting for DM, making hypertension to be a confounder in our study 
population. The fact that many patients have DM and hypertension at the same time might 




In addition to DM, another independent variable associated with peritonitis in this study was 
the black ethnicity. Our multivariate analysis showed that Black Africans had 6-fold higher 
risk of developing peritonitis than other ethnic groups.  The following contributory factors of 
high probability for peritonitis among black South Africans might be: living in less developed 
environment, lower level of education, lower number of qualified professionals, poor housing, 
lack of electricity and water supplies, and the high cost of peritoneal dialysis fluid (Vikrant et 
al. 2013; Troidle et al.1998; Chow et al.2005; Goldie et al.1996).   
Among the socio-demographic factors studied, the present study did not show a significant 
association between age, gender and area of residence and the occurrence of peritonitis among 
CAPD patients. In contrary, a study from Chili reported high incidence of peritonitis among 
patients older than 65 years as compared to younger patients under automated peritoneal 
dialysis (Wang et al. 2001). In addition, during a Brazilian survey on CAPD, peritonitis free-
time-findings were observed similar in patients of all ages, the majority of patients with lower 
socioeconomic status experienced peritonitis while on CAPD modality of treatment (Warady 
et al. 2007). In 2014, another Brazilian study conducted by De Morales et al. reported during 
a study of 474 patients, that an older age was associated with the death during peritonitis, and 
the multivariable regression analysis, non-resolution of peritonitis was independently 
associated with older age, odds ratio (OR)   1.02: p<0.05) The collagenosis amongst the elderly 
patients impacts negatively on treatment and the development of infection like peritonitis in 
CAPD patients. 
The literature also confirms significant associations between dependency on social security 
assistance, lower education level, low income and high risk of peritonitis (Warady et al. 2007; 
Chadha et al. 2010; Piraino et al. 2000). 
In regards to the total number of months of peritonitis free, previous studies in Hong-Kong find 
similar result as ours (Li et al. 2002). However another study in Brazil by Lobo et al. (2010) 
found 28 months of peritonitis free, while the International Peritoneal Dialysis Society 
recommends 18 months, suggesting that we are on a good track as an African country with 
limited resources. 
 
In our study, the following factors were shown to be significantly associated with high 
incidence and early onset of peritonitis after using the Cox regression analysis: age > 40, 
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obesity and DM, while cell count ≥ 1140 in peritoneal dialysis fluid and CRP ≥ 100, and serum 
creatinine >1000.   
The onset of peritonitis among our study population appeared after 19.58 months. Early onset 
of peritonitis was defined as any episode of peritonitis that occurred before 19.58 months of 
starting CAPD. A recent study by Kim et al. (2004) showed that peritonitis occurred within 
seven months following the beginning of CAPD. The difference between our study and the 
study by Kim et al. might due to the fact that our study population was composed of adult 
patients while the study by Kim et al involved children.  
The present study showed however that adults aged > 40 years had early onset of peritonitis. 
Higher peritonitis rate in older patients has been reported by several researchers (Holtta et 
al.1998; Cho et al. 2012; Nishima et al. 2014). In contrary, some studies in developed and 
emerging countries reported earlier onset of peritonitis among patients aged ≥ 65 years (Barretti 
et al. 2007; Cho et al. 2012; Lee et al. 2013). It can be hypothesised that this difference might 
be the result of genetic anticipation (Young et al. (2007).  
The average age of peritonitis patients from our study at IALCH is comparable to a study from 
Senegal that reported the mean age of peritoneal patient to be 49±5 years (Cisse et al. 2012). 
Furthermore,  the majority of patients are black and are from bantu ethnic (Wolof from Senegal, 
and Zulu in South Africa, Xhosa in south Africa, Bakongo from the Democratic Republic of 
Congo) (Longo Mbenza unpublished data), others factors such as poverty, uncontrolled 
hypertension(91,1%)  was more severe among blacks in Africa and Diaspora (Cisse et al. 2012; 
Cisse et al. 2011). 
  
Obesity, an underlying condition associated with DM and hypertension, is also among the 
leading and valid risk factors associated with peritonitis in CAPD patients in many studies 
across the world. (Courivaud et al. 2015; Cho et al. 2014).The results of this study showed a 
positive correlation between patients’ progression to peritonitis and obesity only during 
univariate analysis. In 2013, Nessim et al. enrolled 938 CAPD cases among Canadians patients 
who experienced 1338 peritonitis episodes and 1194 exit –site infections. Their findings 
revealed an increased risk of peritonitis in patients who had the highest BMI quartile (median: 
33.5, interquartile range: 31.9-36.4).  
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The present study has shown that cases of early onset of peritonitis were associated with a 
strong inflammatory response (while cell count ≥ 1140 in peritoneal dialysis fluid and CRP ≥ 
100). In agreement with our findings,   Chow et al. (2014) confirmed that inflammatory 
response at both systemic and local intraperitoneal levels commonly affects PD patients. They 
found that the type of peritoneal dialysis solution might be involved in high inflammatory 
response. However, Hsieh et al (2013) in Taiwan found early peritonitis patients were older, 
with DM and had lower serum creatinine than the late peritonitis patients which is in agreement 
with our findings where  high mean level serum creatinine suggested the End Stage Kidney 
Renal Disease in patients with peritonitis. 
Although this study did not use a data set for weather conditions over prolonged periods of 
time to assess the impact of climate variability on the occurrence of peritonitis, it echoes 
however on the importance of weather and climatic conditions by showing a high variability 
of incidence of peritonitis according to the different seasons over a year. Other studies 
published elsewhere have related weather conditions with the high incidence of peritonitis 
(Okpechi et al. 2010; Vikrant et al. 2013; Piraino et al. 2003; Schaefer et al. 2007). 
In developed and Latin American countries, studies have shown a strong decrease in the 
incidence of peritonitis among patients with CAPD. (Mujais et al. 2006) due to introduction 
and dissemination of novel technology. South Africa like in many developing countries 
however, the delay in the incorporation of novel technologies for patients at the End Stage 
Kidney Renal Disease compounded with high rates of HIV may explain the high incidence of 
peritonitis.  
 
5.3. Microbial agents (and their susceptibility patterns) associated with peritonitis in 
CAPD patients 
The predominant causative agent was Staphylococcus aureus followed by Candida albicans, 
mixed anaerobes and Pseudomonas aeruginosa. The presence of S. aureus and P. aeruginosa 
are strongly suggestive of exit site and tunnel infection respectively. In a Danish nationwide, 
population-based cohort in patients with ESRD conducted by Nielsen et al. (2015), it was 
concluded that patients with ESRD and haemodialysis had increased risk of developing 
Staphyloccoccus aureus bacteraemia as compared to the control groups control groups.                                                              
In Senegal, a study by Niang et al. (2014) found out that S.aureus was the leading cause of 
47 
 
peritonitis. Similarly, findings from Okpechi et al. (2012) at Cape Town in South Africa had 
shown that S.aureus was the most Gram-positive microorganism isolated among CAPD 
patients.  
Although S. epidermidis, a coagulase negative Staphylococcus, was not shown to be 
predominantly associated with peritonitis among our study population, it was however an 
important causative agent in patients with an inserted device. Coagulase negative 
Staphylococci are not generally the cause of infections except for patients with devices such as 
catheters that enable them to form bio-films in order to cause infections. In addition, the formed 
bio-films negatively interfere with the antimicrobial therapy since microorganisms that adhered 
into bio-films down-regulated their metabolic pathways.                                 Another reason 
why coagulase negative Staphylococci can cause infections is immune suppression.  For 
example, diabetic patients are generally immune-compromised patients and therefore are 
vulnerable to   Coagulase negative staphylococcus infection (Ananthakrishnan et al. 2014).  
Fungal peritonitis, often caused by Candida. albicans, mainly occurs in the context of 
inappropriate use of antibacterial broad spectrum therapy. In 2014, Kumar et al reported that 
when fluconazole is used as a prophylactic agent in the setting of bacterial peritonitis might 
significantly reduce the incidence of subsequent fungal peritonitis in CAPD patients.  
Mixed anaerobic bacteria were also found to be among the predominant causative agents of 
peritonitis among CAPD patients. Although the significance of anaerobes is increasingly 
recognised from the literature (Ghali et al. 2011; Chao et al. 2013), the diagnosis of anaerobes 
in our study was only based on microscopic presumptive findings. Confirmation from 
appropriate cultures was not performed.     
Among patients aged below 40 years, P. aeruginosa, S.aureus and mixed anaerobes were 
shown to be the predominant pathogens whilst for older patients (> 40 years), C. albicans, E. 
coli and S. epidermidis were predominant. The difference can be explained at least partially by 
a decreased immune system in older individuals. Moreover, P. aeruginosa and S.aureus have 
necessary virulent factors able to cause infection in young patients. The pathophysiology under 
pinning these findings might also be related to host and/or organisms related factors (Szeto et 
al. 2003; Cho et al. 2012). 
The onset of peritonitis among the study population appeared after 19.58 (±17.98) months of 
undergoing CAPD. Staphylococcus epidermidis and Rhodotorula species (represented as 
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“others”) were shown to cause early onset of peritonitis among CAPD patients whilst S. aureus 
and C. albicans were associated with the late onset of peritonitis. The presence of fungi like 
Rhodotorula spp can be explained by the poor compliance of infection prevention and control 
measures while inserting peritoneal catheter. Rhodotorula spp are common airborne 
contaminant fungi but are most importantly considered as normal inhabitants of the skin, lungs, 
urine, and faeces in humans, hence can become important infectious agents among 
immunocompromised patients. In 2013, a study conducted by Seifi et al. in Iran showed 
Rhodotorula spp as the most contaminant isolated from samples obtained from phones and 
mobiles cellular phones, floor, and windows. 
It can be hypothesised that Rhodotorula spp and S. epidermidis could have been introduced 
during peritoneal catheter insertion due to poor infection prevention and control measures. Due 
to the fact that many CAPD patients become immunocompromised, these microorganisms are 
rapidly able to cause early onset of peritonitis.  
The present study also showed a high rate (35.5%) of peritonitis with negative culture. The 
proportion of culture-negative peritonitis maybe explained by the lack of some laboratory 
services or other pathogens of peritonitis not isolated during routine diagnostic laboratory 
workup. Other reasons might include inadequate sample collection and transport.  This rate of 
peritonitis with culture negative was higher than the rate of 24.7% of peritonitis without 
isolated organism among Korean patients (Kwon et al. 2014). In addition, according to a study 
conducted by Lee et al. (2014), it was found that the incidence of cultures negative among 30 
patients was 24%. Furthermore in another study conducted by Ghali et al. (2011) in Australia 
between October 2003 and December 2008, cases of culture negative peritonitis represented 
13% of the 6639 patients enrolled. Moreover, Kent et al. (2000) and Holley et al. (1989) 
claimed that despite many improvements in culture techniques, negatives cultures account for 
5-33% of catheter related infections, but in 2014 the results from a study conducted by Ram et 
al. showed 33.16% of cultures negatives peritonitis, contrasting with a another one conducted 
by Lan et al. (2014) who concluded that culture negatives were associated with the type of 
peritoneal dialysis. According to these authors, APD was associated with lower rate of culture 





Among the positive cultures, more than 50 % of the isolated micro-organisms were Gram 
positive bacteria. The higher rate of Gram positive reported in this study was similar with that 
from Senegal, West Africa (Cisse et al. 2012). Among the Gram positive organisms, 
Staphylococcus epidermidis and Staphylococcus aureus were the most frequent organisms 
observed in a study in Latin America. (Barretti et al. 2007). 
There was no significant association between gender and pathogens such as Staphyloccocus 
epidermidis, Pseudomonas aeruginosa, Candida albicans, and others micro-organisms.  
However, Escherichia coli isolates were common in females than males; there was males’ 
predominance among patients infected with Staphylococcus aureus. Ethnicity did not impact 
on the incidence of Staphyloccocus aureus,   Escherichia coli, Staphyloccocus epidermidis. 
However, Pseudomonas aeruginosa was predominant among whites but Candida. albicans 
was predominant among coloured patients with peritonitis.  
All isolates of S. aureus were susceptible to cloxacillin, a first-line drug of choice used in the 
management of staphylococcal infections in our facility. The isolate of S. epidermidis was 
however resistant to cloxacillin but susceptible to the second-line vaconmycin. Some isolates 
of Rhodotorula spp were resistant to fluconazole while many isolates of C. albicans were 
susceptible to fluconazole, the first-line antifungal drug used in our facility. All fungi that 
displayed resistance to fluconazole were all shown to be susceptible to amphotericin B. Most 













This study had several limitations. Firstly, we analysed only data from a single centre and also 
we had only few cases of peritonitis; our study design was a retrospective cohort study. 
Secondly, the study population in the present study did not reflect the demographic profile of 
the population in Durban.  
 
Conclusions 
1. Among the causative agents, Staphylococcus aureus, Candida albicans, mixed 
anaerobes and Pseudomonas aeruginosa were the commonest causes of peritonitis 
among the CAPD patients. 
2. Age > 40, obesity and DM, while cell count ≥ 1140 in peritoneal dialysis fluid and CRP 
≥ 100, and serum creatinine >1000 were shown to be significantly associated with high 
prevalence and early onset of peritonitis. 
3. Staphylococcus epidermidis and Rhodotorula species were shown to cause early onset 
of peritonitis among CAPD patients whilst S. aureus and C. albicans were associated 
with the late onset of peritonitis. The presence of fungi like Rhodotorula spp can be 
explained by the poor compliance of infection prevention and control measures while 
inserting peritoneal catheter. Fungus like C. albicans isolates maybe due to prior and 
inadequate use of antimicrobial agents, calling both clinicians and facility managers to 












1. Okpechi IG, Rayner BL, van der Merwe L, Mayosi BM, Adeyemo A, Tiffin N, et 
al.(2010,September 2). Genetic variation at selected SNPs in the leptin gene and 
association of alleles with markers of kidney disease in a Xhosa population of South 
Africa. PLoS One;5(2):e9086. 
2.      The Canada-USA (CANUSA) Peritoneal Dialysis Study Group,Chrchill DN, Taylor       
         DW,Keshavian PR(1996, February ).  
        Adequacy of dialysis and nutrition i  continuous ambulator peritoneal dialysis:     
association with clinical outcomes.   J Am SocNephrol.7(2):198-207.  
 
3. Kerschbaum J, Konig P, Rudnicki M (2012). Risk factors associated with peritoneal-
dialysis-related peritonitis.  International journal of nephrology.  (2012):1-12. 
 4. Vikrant S, Guleria RC, Kanga A, Verma BS, Singh D, Dheer SK. (2013 ,April 13). 
Microbiological aspects of peritonitis in patients on continuous ambulatory peritoneal 
dialysis.Indian J Nephrol. 23(1):12-7.  
5. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F (1998, October 17). Differing 
outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis. 32(4):623-
8.  
6. Prasad N, Gupta A, Sharma RK, Prasad KN, Gulati S, Sharma AP.(2003, December) 
Outcome of gram-positive and gram-negative peritonitis in patients on continuous 
ambulatory peritoneal dialysis: a single-center experience. Perit Dial Int. 23 (2):144-7.  
7. Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK.(2005,July -August)). A 
risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis.  Perit Dial 
Int. 25(4):374-9. 
 8. Dunkle KL, Jewkes RK, Murdock DW, Sikweyiya Y, Morrell R.(2013). Prevalence of 
consensual male-male sex and sexual violence, and associations with HIV in South 
Africa: a population-based cross-sectional study.PLoS Med.  10(6):e1001472.  
9. Goldstein M, Carrillo M, Ghai S.(2013,February). Continuous ambulatory peritoneal 
dialysis-a guide to imaging appearances and complications. Insights into 
imaging.PubMed Central .4(1):85-92 . 
10. National Institute of Health.(2006). Treatment method for kidney failure. Bethesda: The 
clearinghouse; p. 1-24. 
52 
 
11. Vas S, Oreopoulos DG.(2001, September 1). Infections in patients undergoing peritoneal 
dialysis. Infect Dis Clin North Am. 15(3):743-774. 
 12. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, et al.(2000,November). 
Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 
1998.  Am J Kidney Dis. 36(5):1009-13.  
 13. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, et al.(2004,Sept-Oct) Changes 
in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a 
single center's experience over one decade.  
Perit Dial Int. 24(5):424-32.  
 14. Piraino B, Bernardini J, Florio T, Fried L. (2003,Sept-Oct). Staphylococcus aureus 
prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit 
Dial Int.23(5):456-9. 
 15. Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, et al(2007, 
Dec). Worldwide variation of dialysis-associated peritonitis in children.  Kidney Int. 
72(11):1374-9.  
16. Mujais S.(2006 ,Nov) Microbiology and outcomes of peritonitis in North 
America.Kidney Int. (103):55-62. 
 17. Warady BA, Feneberg R, Verrina E, Flynn JT, Muller-Wiefel DE, Besbas N, et al.(2007, 
July). Peritonitis in children who receive long-term peritoneal dialysis: a prospective 
evaluation of therapeutic guidelines. J Am Soc Nephrol. 18(7):2172-9.  
18. Szeto CC, Chow KM, Wong TY, Leung CB, Li PK.(2003, Nov-Dec). Influence of 
climate on the incidence of peritoneal dialysis-related peritonitis.  Perit Dial Int. 
23(6):580-6. 
 19. Martis L, Patel M, Giertych J, Mongoven J, Taminne M, Perrier MA, et al(2005). Aseptic 
peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis 
solution. Lancet. 365(9459):588-94.  
20. Goldie SJ, Kiernan-Tridle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS, et 
al.(1996,  Jul). Fungal peritonitis in a large chronic peritoneal dialysis population: a report 
of 55 episodes. Am J Kidney Dis. 28(1):86-91.  
21. Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, et al(2000 Dec). Factors 
predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year 
experience of fungal peritonitis in a single center.  Am J Kidney Dis. 36(6):1183-92.  
22. Chadha V, Schaefer FS, Warady BA.(2010, Mar). Dialysis-associated peritonitis in 
Children. Pediatr Nephrol. 25(3):425-40.  
53 
 
23. Piraino B.(2000, Oct). Peritoneal infections.  Adv Ren Replace Ther. 7 (4):280-8.  
24. Troidle L, Kliger AS, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein FO. (1996, 
Oct). Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. 
Kidney Int. 50(4):1368-72.  
25. von Baum H, Schehl J, Geiss HK, Schaefer F.(1999, Oct). Prevalence of vancomycin-
resistant enterococci among children with end-stage renal failure. Mid-European 
Pediatric Peritoneal Dialysis Study Group. Clin Infect Dis. 29(4):912-6.  
26. Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, et al.(2012, Jun). 
Consensus guidelines for the prevention and treatment of catheter-related infections and 
peritonitis in pediatric patients receiving peritoneal dialysis: Perit Dial Int. 32(2) : 32-86. 
 27. Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, et 
al.(2008, Mar). Gram-negative peritonitis in children undergoing long-term peritoneal 
dialysis. Am J Kidney Dis. 51(3):455-62. 
 28. Warady BA, Fivush B, Andreoli SP, Kohaut E, Salusky I, Schlichting L, et al (1999, 
Sept). Longitudinal evaluation of transport kinetics in children receiving peritoneal 
dialysis. Pediatr Nephrol. 13(7):571-6.  
29. Alflaiw A, Vas S, Oreopoulos D (1999). Peritonitis in patients on automated peritoneal 
dialysis. Contrib Nephrol. 129:213-28. 
 30. America FMCCN. (2010). Diagnostic and treatment of peritonitis in peritoneal dialysis 
patients. Pages 1-19. Rethrived from: wwwadvancedrenaleducationcom. 
31. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al.(2010,Jul-Aug). 
Peritoneal dialysis-related infections recommendations: update. Perit Dial Int. 30(4):393-
423.  
32. Lioussfi Z, Rhou H, Ezzaitouni F, Ouzeddoun N, Bayahia R, Benamar L.(2012). 
Infectious peritonitis in continuous ambulatory peritoneal dialysis at Rabat University 
Hospital: bacteriological profile over three years]. Pan Afr Med J. 11:41.  
33. Vikrant S.(2014, jun). Long-term clinical outcomes of peritoneal dialysis patients: 9-year 
Experience of a single center from north India.  Perit Dial Int. 34 (4):426-433). 
34. Bunnag S, Thanakitcharu P, Krairittichai U, Jirajan B, Meenune W, Kanjanapanth 
C.(2011, Sept). Risk factors of infectious peritonitis of CAPD patients in Rajavithi 
Hospital. J Med Assoc Thai. 94 ( 4):S37-43. 
 35. Sood MM, Komenda P, Sood AR, Reslerova M, Verrelli M, Sathianathan C, et al.(2010, 
Sept 21). Adverse outcomes among Aboriginal patients receiving peritoneal dialysis. 
CMAJ. 182 (13):1433-1439.  
54 
 
36. Remon-Rodriguez C, Quiros-Ganga P, Portoles-Perez J, Gomez-Roldan C, Miguel-
Carrasco A, Borras-Sans M, et al.(2014). Results of the cooperative study of Spanish 
peritoneal dialysis registries: analysis of 12 years of follow-up. Nefrologia : publicacion 
oficial de la Sociedad Espanola Nefrologia. 34(1):18-33. 
37. de Moraes TP, Olandoski M, Caramori JC, Martin LC, Fernandes N, Divino-Filho JC, et 
al.(2014,Jan 2). Novel predictors of peritonitis-related outcomes in the BRAZPD Cohort. 
Perit Dial Int.34(2):179-187. 
 38. Nessim SJ, Komenda P, Rigatto C, Verrelli M, Sood MM.(2013,Mar-Apr). Frequency 
and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis 
patients. Perit Dial Int. 33(2):167-74. 
 39. Ananthakrishnan S, Sekercioglu N, Elias RM, Kim J, Oreopoulos D, Chu M, et al.(2014, 
Jan) .Peritoneal dialysis outcomes in a modern cohort of overweight patients. Int Urol 
Nephrol. 46(1):183-9. 
 40. Koneman EW, Allen SD, Janda WM, Schreckenber PC, Winn Jr, Gary P et al. (2006). 
Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6th 
ed.Philadelphia,NewYork:Lippincott; p.1226 
41. Holtta TM, Ronnholm KA, Holmberg C.(1998, Nov-Dec). Influence of age, time, and 
peritonitis on peritoneal transport kinetics in children. Perit Dial Int. (6):590-7.  
42. Cisse MM, Hamat I, Gueye S, Seck SM, Ka el HF, Tall AO, et al.(2012, Sept). Peritonitis 
in patients on peritoneal dialysis: a single-center experience from Dakar. Saudi J Kidney 
Dis Transpl. 23(5):1061-4. 
 43. Barretti P, Bastos KA, Dominguez J, Caramori JC.(2007,May-Jun). Peritonitis in Latin 
America. Perit Dial Int. 27(3):332-9  
44. Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, et al.(2012). 
Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry 
study. Nephrology Dialysis Transplantation.27(5):2028-36. 
45. Cisse MM, Ka E, Gueye S, Seck SM, Tall A, Niang A, et al.(2011, Mar-Oct). [Peritoneal 
dialysis in a tropical area, a reality]. Med Trop .71(5):468-71.  
46. Nishina M, Yanagi H, Kakuta T, Endoh M, Fukagawa M, Takagi A.(2014,Aug). A 10-
year retrospective cohort study on the risk factors for peritoneal dialysis-related 




47. Lee KO, Park SJ, Kim JH, Lee JS, Kim PK, Shin JI.(2013, Jul). Outcomes of peritonitis 
in children on peritoneal dialysis: a 25-year experience at Severance Hospital. Yonsei 
Med J. 54(4):983-9. 
 48. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, et al(1994). Ten 
years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian 
Cooperative Peritoneal Dialysis Study Group. Nephrol Dial Transplant. 9(10):1443-8. 
49.   Caramori JCT.(1999). peritonites em pacientes tratados com dialise peritoneal  
ambulatorial continua:estudo clinico e microbiologico.Sao Paulo: Faculdade de medecina de   
botucatu,universidade estadual paulista.  
 
50.  Li PK. (2002). "Comparison of clinical outcome and ease of handling in two double-bag 
systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, 
controlled, multicenter study." Am J Kidney Dis 40(2): 373-380. 
51. Lobo JV. (2010). "Predictor factors of peritoneal dialysis-related peritonitis." J Bras Nefrol 
32(2): 156-164. 
52. Lee SM, Nam HS, Jeong EG, Son KY, Kim SE, An WS et al.(2014).Comparison of exit 
site infection and Peritonitis incidences between providone-iodine and normal saline use 
for chronic exit site care in peritoneal dialysis patients. Kidney Research and Clinical 
Practice. 3(33):144-149. 
53. Kent JR; Almond MK. (2000, May-Jun). A survey of CAPD peritonitis management and 
outcomes in North and South Thames NHS regions (UK): support for the ISPD 
guidelines. Perit Dial Int, 20(3), 301-307. 
54. Holly JL; Moss AH. (1989, March). A prospective evaluation of blood culture versus 
standard plate techniques for diagnosing peritonitis in CAPD. Am J Kidney Dis, 13(3), 
184-188. 
55. Kwon JE, Koh SJ, Chun J, Kim JW, Kim BG, Lee KL, et al(2014).Effect of gastrtric acid 
suppressants and prokinetics on peritoneal dialysis related peritonitits.World J Gastro 
enterol. 20 (25):8187-8194 
56. Kumar KV, Mallikarjuna HM, Gokulnath, Jayanthi S. (2014,Sept-Oct). Fungal peritonitis 
in continuous ambulatory peritoneal dialysis :The impact of antifungal prophylaxis on 
patient and technique outcomes. Indian J Nephrol. 24(5):297-301. 
56 
 
57. Lan PG, Johnson DW, McDonald SP, Boudville N, Borlace M, Badve SV et al. (2014, June 
6). The association between peritoneal dialysis modality and Peritonitis. Clin J Am Soc 
Nephrol. 9 (60):1091-7. 
58. Ram R, Swarnalatha G, Rao CSS, Naidu D, Sriram S ,  Dakshinamurty. (2014, Mar-Apr). 
Risk factors that determine removal of catheter in bacterial peritonis in peritoeal dialysis. 
Perit Dial Int. 34(2):239-243. 
59. Cho YJ, Hawley CM, Johnson DW.(2014) Clinical causes of inflammation in peritoneal 
dialysis patients. Int J of Nephrol (2014):1-9.  
60. Chow KM, Szeto CC, Kwan BCH, Pang WF, Ma T, Leung CB et al.(2014, jul). 
Randomised controlled study of icodextrin on the treatment of peritoneal dialysis patients 
during acute peritonitis. Nephrol Dial Transplant  29 (7):1438-1443. 
61. Hsieh YP, Wang SC, Chang CC, Wen YK, Chiu PF , Yang W. (2014,Sept-Oct). The 
negative impact of  early peritonitis on continuous ambulatory peritoneal dialysis patients. Perit 
Dial Int. 34 (6):627-635. 
62. Dong J, Chen Y, Luo S, Xu R, Xu Y. (2013, May-Jun). Peritoneal protein leakages, 
systemic inflammation, and peritonitis risks in patients on peritoneal dialysis. Perit Dial Int . 
33(3):273-279. 
63. Nielsen LH, Fanger SJ, Benfield T, Skov R, Jespersen B, Larsen AR et al. (2015). Risk and 
prognosis of Staphyloccocus aureus bacteremia among individuals with and without end stage 
renal diseases:a Danish,population-based cohort study .BMC  Infections Diseases. (15):1-8 
64. Seifi Z, Mahmoudabadi AZ, Hydrinia S (2013, Aug 10). Isolation, Identification and 
Susceptibility profile of Rhodotorula species isolated from Educational Hospitals in Ahvaz. 
Jundishapur Journal of Microbiology, 6 (6): 1-8. 
65. Yap Desmond YH, Chu WL, Ng F, Yip TPS, Lui SL, Lo WK (2012, Nov-Dec): Risks 
factors and outcomes of contamination in patients on peritoneal dialysis :A single center 
experience of 15 years. Perit  Dial Int. 32 ( 6): 612-616. 
66. Chao CT, Lee SY, Yang WS, Chen HW, Fang CC, Yen CJ et al.(2013). Peritoneal dialysis 




67. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW et al.(2011, 
Nov-Dec). The microbiology and Outcomes of peritonitis in Australian Peritoneal Dialysis 
Patients.Perit  Dial Int .31(6): 651-662. 
68. Mizumasa T, Hirakata H, Tsuruya K, Katafuchi R, Yotsueda H, Mitsuiki K et 
al.(2013,March-April). Diabetes influences peritoneal: morphology in uremic patients at the 
initiation of peritoneal dialysis. Perit Dial Int.  33 (2) :175-181. 
 
69.Niang A, Cisse MM, Lemrabott ATO, Mahmoud SMM, Ka EHF, Diouf B. (2014, Jul-Aug). 
Pilot Expereince in Senegal with peritoneal dialysis for end stage renal disease. Perit Dial int.34 
(5): 539-543. 
70 . Young S and Chan TM.(2007,Jul-Aug). Peritoneal proteoglycans: Much more than ground 
substance. Perit Dial Int. 27 ( 4 ):375-390. 
71. Courivaud C, Bardonnet K, Crepin T, Bresson-Vautrin C, Rebibou JM, Ducloux D. Serum 
Immunoglobulin G levels and Peritonitis in peritoneal dialysis patients.  Journal of Nephro 
March 2015 DOI 10.1007/s40620-015-0176-2. 
72. Cho Y and Johnson DW. (2014, Aug). Peritoneal Dialysis-Related Peritonitis: Towards 
Improving Evidence, Practices, and outcomes. Am Journal of Kidney Diseases. 64 (2):  278-
289. 
73. Abu-Aisha H, Elamin S (2010, Jan- Feb). Peritoneal Dialysis in Africa. Pert Dial Int 33. 
(1):23-28 
74. Beck RB (2013). The History of South Africa. 2th ed.page 4. 
 
 
 
 
 
 
